Caterina Lapenta

2.5k total citations · 1 hit paper
38 papers, 2.0k citations indexed

About

Caterina Lapenta is a scholar working on Immunology, Virology and Oncology. According to data from OpenAlex, Caterina Lapenta has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 12 papers in Virology and 9 papers in Oncology. Recurrent topics in Caterina Lapenta's work include Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (15 papers) and T-cell and B-cell Immunology (13 papers). Caterina Lapenta is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (15 papers) and T-cell and B-cell Immunology (13 papers). Caterina Lapenta collaborates with scholars based in Italy, United States and Australia. Caterina Lapenta's co-authors include Stefano M. Santini, Filippo Belardelli, Mariantonia Logozzi, Massimo Spada, Stefania Parlato, Tiziana Di Pucchio, Stefano Fais, Simona Donati, Maria Ferrantini and Francesca Spadaro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Caterina Lapenta

37 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice

2000 535 citations Stefano M. Santini, Caterina Lapenta et al. profile →

Peers

Countries citing papers authored by Caterina Lapenta

Since Specialization

Citations

This map shows the geographic impact of Caterina Lapenta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Lapenta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Lapenta more than expected).

Fields of papers citing papers by Caterina Lapenta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caterina Lapenta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Lapenta. The network helps show where Caterina Lapenta may publish in the future.

Co-authorship network of co-authors of Caterina Lapenta

This figure shows the co-authorship network connecting the top 25 collaborators of Caterina Lapenta. A scholar is included among the top collaborators of Caterina Lapenta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caterina Lapenta. Caterina Lapenta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC) 2024 ·Vaccines ·Caterina Lapenta, Stefano M. Santini, (unknown), Simona Donati, Serena Cecchetti, (unknown), Piera Catalano, Francesca Urbani, Iole Macchia, Massimo Spada, Sara Vitale, Zuleika Michelini, Domenico Corsi, Ann Zeuner, Rosanna Dattilo, Manuela Tamburo De Bella	0
2	CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis 2023 ·Immunology ·Giulia Romagnoli, Quintino Giorgio D’Alessandris, Imerio Capone, Andrea Tavilla, Irene Canini, Caterina Lapenta, Mariachiara Buccarelli, Martina Giordano, Valentina Tirelli, Massimo Sanchez, Alessandra Fragale, Stefano Giannetti, Rina Di Bonaventura, Liverana Lauretti, Mauro Biffoni, Lucia Ricci‐Vitiani, Roberto Pallini, Lucia Gabriele	7
3	IFN-Alpha-Mediated Differentiation of Dendritic Cells for Cancer Immunotherapy: Advances and Perspectives 2020 ·Vaccines ·Caterina Lapenta, Lucia Gabriele, Stefano M. Santini	17
4	Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma 2020 ·Cancer Immunology Immunotherapy ·Maria Christina Cox, Caterina Lapenta, Stefano M. Santini	10
5	Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19 2020 ·Cytokine & Growth Factor Reviews ·Lucia Gabriele, Alessandra Fragale, Giulia Romagnoli, Stefania Parlato, Caterina Lapenta, Stefano M. Santini, Keiko Ozato, Imerio Capone	15
6	Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine 2019 ·Cancer Immunology Immunotherapy ·Caterina Lapenta, Simona Donati, Francesca Spadaro, Laura Lattanzi, Francesca Urbani, Iole Macchia, (unknown), Massimo Spada, Maria Christina Cox, Filippo Belardelli, Stefano M. Santini	20
7	Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12 2011 ·PLoS ONE ·Stefano M. Santini, Caterina Lapenta, Simona Donati, Francesca Spadaro, Filippo Belardelli, Maria Ferrantini	57
8	Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells 2011 ·Vaccine ·Antonella Sistigu, Laura Bracci, Mara Valentini, Enrico Proietti, Roberta Bona, Donatella Negri, Anna Rita Ciccaglione, Elena Tritarelli, Roberto Nisini, Michele Equestre, Angela Costantino, Cinzia Marcantonio, Stefano M. Santini, Caterina Lapenta, Simona Donati, (unknown), (unknown), Andrea Cara, Maurizio Federico	16
9	Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein 2009 ·Virology ·Paola Di Bonito, Felicia Grasso, (unknown), Linda Petrone, Emanuele Fanales‐Belasio, Arianna Mei, (unknown), (unknown), Heinke Conrad, Helga Bernhard, Claudia J. Dembek, Antonio Cosma, Stefano M. Santini, Caterina Lapenta, Simona Donati, Claudia Muratori, Colomba Giorgi, Maurizio Federico	38
10	In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma 2009 ·European Journal of Cancer ·(unknown), A. C. SAU, Silvia Pezzola, Cristina Geroni, Caterina Lapenta, Massimo Spada, Giuseppe Filomeni, Elena Bonanno, Giorgio Federici, Anna Maria Caccuri	31
11	IFN-alpha in the Generation of Dendritic Cells for Cancer Immunotherapy 2008 ·Handbook of experimental pharmacology ·Stefano M. Santini, Caterina Lapenta, Laura Santodonato, Giuseppina D’Agostino, Filippo Belardelli, Maria Ferrantini	49
12	Differentiation of monocyte‐derived dendritic cells is associated with upregulation and activation of Rac‐1 small GTPase 2006 ·FEBS Letters ·Anna Maria Giammarioli, Lucrezia Gambardella, Maria Giovanna Quaranta, Caterina Lapenta, Stefano M. Santini, Filippo Belardelli, Marina Viora, Walter Malorni	4
13	Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice 2005 ·International Immunology ·Caterina Lapenta	13
14	CD2⁺/CD14⁺ monocytes rapidly differentiate into CD83⁺ dendritic cells 2003 ·European Journal of Immunology ·Tiziana Di Pucchio, Caterina Lapenta, Stefano M. Santini, Mariantonia Logozzi, Stefania Parlato, Filippo Belardelli	22
15	The Natural Alliance Between Type I Interferon and Dendritic Cells and Its Role in Linking Innate and Adaptive Immunity 2002 ·Journal of Interferon & Cytokine Research ·Stefano M. Santini, Tiziana Di Pucchio, Caterina Lapenta, Stefania Parlato, Mariantonia Logozzi, Filippo Belardelli	68
16	Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides 2001 ·AIDS ·Simonetta Di Fabio, Giacomo Giannini, Caterina Lapenta, Massimo Spada, Andrea Binelli, Elena Germinario, Paola Sestili, Filippo Belardelli, Enrico Proietti, Stefano Vella	37
17	Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive Fas-mediated autocrine suicide of uninfected cells 2000 ·Cell Death and Differentiation ·Stefania Parlato, Stefano M. Santini, Caterina Lapenta, Massimo Spada, Mariantonia Logozzi, Paola Rizza, Enrico Proietti, Filippo Belardelli, Stefano Fais	8
18	Type I Interferon Is a Powerful Inhibitor of in Vivo HIV-1 Infection and Preserves Human CD4+ T Cells from Virus-Induced Depletion in SCID Mice Transplanted with Human Cells 1999 ·Virology ·Caterina Lapenta, Stefano M. Santini, Enrico Proietti, Paola Rizza, Mariantonia Logozzi, Massimo Spada, Stefania Parlato, Stefano Fais, Paula M. Pitha, Filippo Belardelli	42
19	Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection 1999 ·European Journal of Immunology ·Caterina Lapenta, Monica Boirivant, Marco Marini, Stefano M. Santini, Mariantonia Logozzi, Marina Viora, Filippo Belardelli, Stefano Fais	89
20	TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY MICE WITH ANTI-MURINE GRANULOCYTE MONOCLONAL ANTIBODY IMPROVES HUMAN LEUKOCYTE XENOTRANSPLANTATION1 1998 ·Transplantation ·Stefano M. Santini, Massimo Spada, Stefania Parlato, Mariantonia Logozzi, Caterina Lapenta, Enrico Proietti, Filippo Belardelli, Stefano Fais	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact